Distributing Health, Beauty Products To Retailers, Hims & Hers Seeds Field For OTC ED Drug Sales
With ED ingredients frequently mentioned as OTC switch candidates in US, Hims & Hers Health is another latest direct-to-consumer marketer establishing network of retailers to offer potential OTC ED drug as it makes its consumer health and personal care products available in stores.
You may also be interested in...
Ro acquires Dadi specializing in sperm testing, analysis and storage, two weeks after adding $150m funding and 10 months after entering female fertility product market with acquisition of Modern Fertility.
The German Expert Committee for Prescription has rejected the Rx-to-OTC reclassifications of sildenafil (50mg) for oral use and xylometazoline and ipratropium bromide for intranasal use.
Firms also notes in its announcement that FDA typically requires actual use trials for switch NDAs in addition to label comprehension studies, which it has conducted, and self-selection studies.